JPRN-jRCT2080222300未知2 期
A Phase 2B/3 Open-label Study of EPI-743 in Children with Leigh Syndrome
试验速览
- 阶段
- 2 期
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 17age old（—）
- 性别
- All
入选标准
- •- Clinical and MRI diagnosis of Leigh syndrome
排除标准
- •- Allergy to EPI-743 or sesame oil
- •- Allergy to vitamin E
- •- Diagnosis of any other concurrent inborn error of metabolism
研究者
相似试验
进行中（未招募）
不适用
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease. - E7389-G000-211ocally advanced or metastatic breast cancerMedDRA version: 8.1Level: PTClassification code 10055113EUCTR2005-003656-35-ATEisai Limited300
进行中（未招募）
不适用
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease. - E7389-G000-211EUCTR2005-003656-35-DEEisai Limited300
进行中（未招募）
不适用
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease. - E7389-G000-211EUCTR2005-003656-35-ESEisai Limited300
进行中（未招募）
不适用
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease. - E7389-G000-211EUCTR2005-003656-35-BEEisai Limited300
进行中（未招募）
1 期
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease. - E7389-G000-211ocally advanced or metastatic breast cancerMedDRA version: 8.1 Level: PT Classification code 10055113EUCTR2005-003656-35-GBEisai Limited300